Preview Mode Links will not work in preview mode

This Week in Cardiology

May 12, 2023

Two new papers on left atrial appendage occlusion, the promise of DNA, statins in the elderly, and SGLT2 inhibitors are the topics John Mandrola, MD, discusses in this week's podcast.

This podcast is intended for healthcare professionals only.

To read a partial transcript or to comment, visit:

I. Listener Feedback

- When to Start a Statin Is a Preference-Sensitive Decision

II. Left Atrial Appendage Closure

LAA Closure Outcomes Improve With CCTA: Swiss-Apero Subanalysis

- Impact of Preprocedural Computed Tomography on Left Atrial Appendage Closure Success: A Swiss-Apero Trial Subanalysis

- Outcomes of percutaneous left atrial appendage occlusion device implantation in atrial fibrillation patients based on underlying stroke risk

III. Polygenic Risk Scores

- Predictive Accuracy of a Polygenic Risk Score Compared With a Clinical Risk Score for Incident Coronary Heart Disease

- Cardiovascular Disease Risk Assessment Using Traditional Risk Factors and Polygenic Risk Scores in the Million Veteran Program

- Validity of polygenic risk scores: are we measuring what we think we are?

IV. Statins in Older Patients

High Cholesterol in Seniors: Use Statins for Primary Prevention?

V. SGLT2 Inhibitors

FDA Expands Use of Dapagliflozin to Broader Range of HF

- Dapagliflozin in Heart Failure with Mildly Reduced or Preserved Ejection Fraction

You may also like:

Medscape editor-in-chief Eric Topol, MD, and master storyteller and clinician Abraham Verghese, MD, on Medicine and the Machine

The Bob Harrington Show with Stanford University Chair of Medicine, Robert A. Harrington, MD.

Questions or feedback, please contact